What is the recommended dosage of tramadol (ultram) for patients with impaired renal function (dialysis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tramadol Dosing in Dialysis Patients

For patients on dialysis, tramadol should be administered at a maximum dose of 200 mg/day with an extended dosing interval of 12 hours. 1

Dosing Recommendations Based on Renal Function

  • For patients with creatinine clearance less than 30 mL/min (including those on dialysis), the dosing interval should be increased to 12 hours, with a maximum daily dose of 200 mg 1
  • Since only 7% of an administered dose is removed by hemodialysis, dialysis patients can receive their regular dose on the day of dialysis without additional adjustments 1
  • Lower doses are recommended for patients with hepatic and/or renal dysfunction to reduce the risk of seizures 2

Pharmacokinetic Considerations in Renal Impairment

  • Tramadol is primarily metabolized by the liver via O- and N-demethylation and conjugation reactions forming glucuronides and sulfates 3
  • The main active metabolite O-desmethyl-tramadol (M1) has a higher affinity for opioid receptors than the parent drug 4
  • Tramadol and its metabolites are mainly excreted via the kidneys, making dose adjustment necessary in renal impairment 3
  • The mean elimination half-life of tramadol is about 6 hours in patients with normal renal function, but can be prolonged in renal impairment 3, 5

Monitoring Recommendations

  • Assess renal function before initiating therapy and periodically during treatment 6
  • For patients with fluctuating renal function, reassess GFR every 2-3 days to adjust dosing as needed 6
  • Monitor for signs of opioid toxicity, including respiratory depression, excessive sedation, and seizures 2
  • Pay special attention to elderly patients who often have decreased renal function even with normal serum creatinine levels 6

Safety Considerations and Adverse Effects

  • Tramadol has dual mechanisms of action: weak mu-opioid receptor agonism and inhibition of norepinephrine and serotonin reuptake 2
  • Common adverse effects include dizziness, nausea, dry mouth, and sedation 7
  • Tramadol should be used with caution or avoided in patients taking other serotonergic medications (e.g., SSRIs, TCAs, MAOIs) due to risk of serotonin syndrome 2
  • Cases of acute kidney injury have been reported with tramadol overdose, highlighting the importance of appropriate dosing in patients with pre-existing renal impairment 8

Alternative Analgesics for Dialysis Patients

  • Fentanyl and buprenorphine (transdermal or intravenous) are considered the safest opioids for patients with severe renal impairment or on dialysis 9
  • Buprenorphine may be especially appropriate for treating pain in patients with renal impairment based on its pharmacokinetics 2
  • Hydromorphone and oxycodone can be used with caution and dose adjustment in renal insufficiency 9
  • Methadone (when administered by clinicians experienced in its use) can be used in renal insufficiency 9

Special Populations

  • For elderly patients over 75 years old, total dose should not exceed 300 mg/day even with normal renal function 1
  • In elderly patients with renal impairment who are on dialysis, the dose should be further reduced to follow the 200 mg/day maximum with 12-hour dosing interval 1
  • Dose selection for elderly patients should be cautious, usually starting at the low end of the dosing range 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical pharmacology of tramadol.

Clinical pharmacokinetics, 2004

Research

[Pharmacology of tramadol].

Drugs, 1997

Guideline

Dosing of Amoxicillin-Clavulanate in Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tramadol: a new centrally acting analgesic.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997

Research

Acute Tramadol Ingestion With Transient Acute Kidney Injury in an Adolescent Female.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2021

Guideline

Codeine Dosage Adjustment in Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.